References
Statland M, Ciafaloni E (2013) Myasthenia gravis: five new things. Neurology Clinical Practice 3:126–133
Ferrero B, Durelli L (2002) High-dose intravenous immunoglobulin G treatment of myasthenia gravis. Neurological Sciences Suppl 23:9–24
Padua L, Caliandro P, di Iasi G, Pazzaglia C, Ciarraffa F, Evoli A. Reliability of SFEMG in diagnosing myasthenia gravis: sensitivity and specificity calculated on 100 consecutive cases. Clin Neurophysiol 2014 125(6):1270–1273. https://doi.org/10.1016/j.clinph.2013.11.005
Davis S, Schumacher MJ (1979) Myasthenia gravis and lymphoma. A clinical and immunological association. JAMA 42:2096–2097
Rezania K, Soliven B, Baron J, Lin H, Penumalli V, van Besien K (2011) Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leukemia & Lymphoma 53(3):371–380. https://doi.org/10.3109/10428194.2011.615426
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rutar Gorišek, V., Zupančič, D., Zidar, J. et al. Diffuse large B cell lymphoma mimics myasthenia gravis. Neurol Sci 41, 727–728 (2020). https://doi.org/10.1007/s10072-019-04074-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-04074-0